Informations générales (source: ClinicalTrials.gov)
Impact of Probiotic Regimen on Vancomycin Resistant Enterococcus (VRE) Intestinal Carriage : a Double Blind Randomized Pilot Study
Interventional
Phase 4
University Hospital, Clermont-Ferrand (Voir sur ClinicalTrials)
février 2007
août 2009
29 juin 2024
This study aims to reduce the duration of VRE intestinal carriage by the administration
of Lactobacillus casei rhamnosus (strain Lcr 35 LC). Patients will be blindly randomized
to be assigned to a 5 weeks regimen with the probiotic (10 9 lactobacillus bid) or to a 5
weeks regimen with placebo.A stool culture will be performed every week for 5 weeks
(during the administration of treatment) then every two weeks until 3 consecutive
negative stool culture for VRE.
Etablissements
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| Service des Maladies infectieuses et tropicales - 63003 - Hôpital Gabriel Montpied - Clermont-Ferrand - France | Contact (sur clinicalTrials) | ||||
Critères
Tous
Inclusion Criteria:
- Age >18;
- Vancomycin Resistant Enterococcus intestinal carriage
- Age >18;
- Vancomycin Resistant Enterococcus intestinal carriage
- Neutropenia <1000 /mm3,
- Immunosuppressive drugs,
- Inhalation